Casablanca Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.80 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 11.69%
- Ebitda 20.10%
- Net Worth -11.65%
- Total Assets -5.84%
About Casablanca Pharma
Casablanca Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 June 2017 (Seven years and seven months 25 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.80 M, as per Ministry of Corporate Affairs (MCA) records.
Rajeev Juneja, Arjun Juneja, and Sheetal Arora serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U93090DL2017PTC318888
-
Company No.
318888
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jun 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Casablanca Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Juneja
|
Director | 08-Jun-2017 | Current |
|
Arjun Juneja
|
Director | 08-Jun-2017 | Current |
|
Sheetal Arora
|
Director | 08-Jun-2017 | Current |
Financial Performance of Casablanca Pharma.
Casablanca Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 11.69% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Casablanca Pharma?
In 2020, Casablanca Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Phd Chamber Of Commerce And IndustryRajeev Juneja is a mutual person
-
Bharat Serums And Vaccines LimitedRajeev Juneja, Arjun Juneja and 1 more are mutual person
-
The Hi-Tech Gears LimitedArjun Juneja is a mutual person
-
Pathkind Diagnostics Private LimitedRajeev Juneja, Arjun Juneja and 1 more are mutual person
-
Mankind Pharma LimitedRajeev Juneja and Sheetal Arora are mutual person
-
Appian Projects LlpRajeev Juneja, Arjun Juneja and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Casablanca Pharma?
Unlock and access historical data on people associated with Casablanca Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Casablanca Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Casablanca Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.